Cargando…

Nebuliser hygiene in cystic fibrosis: evidence-based recommendations

Nebulised therapies are extensively used in the daily therapeutic management of cystic fibrosis both for mucociliary clearance and for the management of chronic infections. Extensive developments have been made in relation to nebulised drug delivery mechanisms and drug formulations, and guidelines h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bell, Jane, Alexander, Lauren, Carson, Jane, Crossan, Amanda, McCaughan, John, Mills, Hazel, O'Neill, Damian, Moore, John E., Millar, B. Cherie
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2020
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7341620/ https://www.ncbi.nlm.nih.gov/pubmed/32684992 http://dx.doi.org/10.1183/20734735.0328-2019

Ejemplares similares

Thinking inside the box: nebulizer care, safe storage, and risk of infection in cystic fibrosis
por: Alexander, Lauren, et al.
Publicado: (2020)

The virtual CF clinic: Implications for sputum microbiology
por: Moore, John E., et al.
Publicado: (2021)

INCREASING BURDEN OF ANTIMICROBIAL RESISTANCE IN PSEUDOMONAS AERUGINOSA FROM ADULT PATIENTS WITH CYSTIC FIBROSIS (CF) IN NORTHERN IRELAND: THEN AND NOW
por: Gramegna, Andrea, et al.
Publicado: (2018)

Who’s at The Door? – Surface Contamination of Door Frames in a Single-Bedded In-Patient Adult Cystic Fibrosis (CF) Unit
por: Furukawa, Maika, et al.
Publicado: (2020)

The Microbiology of Non-aeruginosa Pseudomonas Isolated From Adults With Cystic Fibrosis: Criteria to Help Determine the Clinical Significance of Non-aeruginosa Pseudomonas in CF Lung Pathology
por: Moore, John E., et al.
Publicado: (2022)

STAPHYLOCOCCUS AUREUS ENTEROTOXINS IN PEOPLE WITH CYSTIC FIBROSIS (CF)
por: Wen, Hongjie, et al.
Publicado: (2020)

THE MICROBIOLOGY OF THE CAMÁN
por: Moore, John E., et al.
Publicado: (2020)

Vibrating Mesh Nebulisation of Pro-Antimicrobial Peptides for Use in Cystic Fibrosis
por: Forde, Éanna, et al.
Publicado: (2019)

CONCERNS FOR PEOPLE WITH CYSTIC FIBROSIS (PWCF) WHEN TRAVELLING PRE COVID-19
por: O’Doherty, Megan, et al.
Publicado: (2022)

MRSA eradication of newly acquired lower respiratory tract infection in cystic fibrosis
por: Vallières, Emilie, et al.
Publicado: (2016)

Differential Performance and Lung Deposition of Levofloxacin with Different Nebulisers Used in Cystic Fibrosis
por: Schwarz, Carsten, et al.
Publicado: (2022)

Lung function and disease severity in cystic fibrosis patients heterozygous for p.Arg117His
por: Shteinberg, Michal, et al.
Publicado: (2017)

Development of an intervention to increase adherence to nebuliser treatment in adults with cystic fibrosis: CFHealthHub
por: Arden, M. A., et al.
Publicado: (2021)

Case Report: Dual nebulised antibiotics among adults with cystic fibrosis and chronic Pseudomonas infection
por: Mann, Nina, et al.
Publicado: (2018)

Public Health Bacteriology of Commercially Composted Domestic Food and Garden Waste by the 11 Councils in Northern Ireland – Persistence Of Clostridium perfringens and Implications for Local Food Safety
por: Furukawa, Maika, et al.
Publicado: (2018)

Objective Nebuliser Adherence Data as “Proof” of Adherence in the Management of Cystic Fibrosis: A Qualitative Interview Study
por: Lumley, Elizabeth, et al.
Publicado: (2022)

TACKLING ANTIMICROBIAL RESISTANCE (AMR) - IN VITRO EFFECT OF SODIUM CHLORIDE ON ANTIBIOTIC SUSCEPTIBILITY IN CLINICAL PSEUDOMONAS AERUGINOSA ISOLATED FROM PATIENTS WITH CYSTIC FIBROSIS (CF)
por: Gramegna, Andrea, et al.
Publicado: (2020)

Investigating the Temporal Relationships between Symptoms and Nebuliser Adherence in People with Cystic Fibrosis: A Series of N-of-1 Observations
por: Martin, Rosie, et al.
Publicado: (2020)

P121 The effect of training about nebuliser cleaning and disinfection on the knowledge levels and practises of the caregivers of patients with cystic fibrosis
por: Cenk, M., et al.
Publicado: (2021)

Single-arm, open-labelled, safety and tolerability of intrabronchial and nebulised bacteriophage treatment in children with cystic fibrosis and Pseudomonas aeruginosa
por: Singh, Jagdev, et al.
Publicado: (2023)

Emulated trial investigating effects of multiple treatments: estimating combined effects of mucoactive nebulisers in cystic fibrosis using registry data
por: Granger, Emily, et al.
Publicado: (2023)

Early detection of Pseudomonas aeruginosa – comparison of conventional versus molecular (PCR) detection directly from adult patients with cystic fibrosis (CF)
por: Xu, Jiru, et al.
Publicado: (2004)

Repeated nebulisation of non-viral CFTR gene therapy in patients with cystic fibrosis: a randomised, double-blind, placebo-controlled, phase 2b trial
por: Alton, Eric W F W, et al.
Publicado: (2015)

Zanamivir should be inhaled, not nebulised
por: Eagel, Barry A
Publicado: (2010)

Double Nebulisation for Airway Anaesthesia
por: Chugh, Vanya, et al.
Publicado: (2020)

Understanding patient activation and adherence to nebuliser treatment in adults with cystic fibrosis: responses to the UK version of PAM-13 and a think aloud study
por: Gao, Jie, et al.
Publicado: (2019)

Clinical pharmacokinetics and dose recommendations for posaconazole gastroresistant tablets in children with cystic fibrosis
por: Bentley, Siân, et al.
Publicado: (2021)

P141 Has the COVID-19 pandemic affected medication adherence to inhaled nebulised therapy for patients at a large adult cystic fibrosis centre?
por: Iqbal, N., et al.
Publicado: (2021)

P409 Monitoring adherence to nebulised therapies during the first UK lockdown and school closure period of the COVID-19 pandemic in children with cystic fibrosis
por: Smith, C., et al.
Publicado: (2023)

Airway inflammatory markers in individuals with cystic fibrosis and non-cystic fibrosis bronchiectasis
por: Bergin, David A, et al.
Publicado: (2013)

Oral Care Recommendation for Cystic Fibrosis Patients–Recommendation for Dentists
por: Pawlaczyk-Kamieńska, Tamara, et al.
Publicado: (2022)

Coinfection with Pseudomonas aeruginosa and Aspergillus fumigatus in cystic fibrosis
por: Keown, Karen, et al.
Publicado: (2020)

The use of an alternate side lying positioning strategy during inhalation therapy does not prolong nebulisation time in adults with Cystic Fibrosis: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2018)

Nebulised surfactant to reduce severity of respiratory distress: a blinded, parallel, randomised controlled trial
por: Minocchieri, Stefan, et al.
Publicado: (2019)

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
por: Floto, R Andres, et al.
Publicado: (2016)

Future therapies for cystic fibrosis
por: Allen, Lucy, et al.
Publicado: (2023)

Side lying during nebulisation can significantly improve apical deposition in healthy adults and adults with mild cystic fibrosis lung disease: a randomised crossover trial
por: Dentice, Ruth L., et al.
Publicado: (2019)

Nebulisers as a potential source of airborne virus
por: Tang, Julian W., et al.
Publicado: (2020)

A phase 1 trial of nebulised heparin in acute lung injury
por: Dixon, Barry, et al.
Publicado: (2008)

Shortened Lung Clearance Index is a repeatable and sensitive test in children and adults with cystic fibrosis
por: Hannon, David, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d5b89b8cn82c6k4iuo519eaii0